Novartis AG (NOTA STU) stock market data APIs
€108.0603
-0.76(-0.7%)
as of September 12, 2025
Try our APIs with
free plan!
Novartis AG Financial Data Overview
Price chart is built with
Anychart
Prev. Close
108.0603
Open
107.3041
High
107.3041
Low
105.0938
52 wk Range
87.4-110.5
Market Cap
160 075 M
Dividends (Yield)
0.0356
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novartis AG data using free add-ons & libraries
Get Novartis AG Fundamental Data
Novartis AG Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novartis AG News
New
Incyte Gears Up to Report Q1 Earnings: Here's What You Should Know
Incyte Corporation INCY is expected to beat estimates when it reports first-quarter 2025 earnings results on April 29, before the opening bell. The Zacks Consensus Estimate for the to-be-reported q...
European pharma companies push for higher drug prices in EU amid U.S. tariff threats
By Maggie Fick (Reuters) -European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., wher...
Novartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?
Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks Consensus Estimate for revenues is pegged at $12.86 billion, while the same for e...
Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
